Promimic AB (publ)

OM:PRO Stock Report

Market Cap: SEK 198.4m

Promimic Past Earnings Performance

Past criteria checks 0/6

Promimic has been growing earnings at an average annual rate of 9.1%, while the Life Sciences industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 37.4% per year.

Key information

9.10%

Earnings growth rate

21.37%

EPS growth rate

Life Sciences Industry Growth31.84%
Revenue growth rate37.36%
Return on equity-14.81%
Net Margin-17.15%
Last Earnings Update31 Dec 2025

Recent past performance updates

Recent updates

Analysis Article Nov 02

Promimic (STO:PRO) Is In A Good Position To Deliver On Growth Plans

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
Analysis Article Jul 14

We're Hopeful That Promimic (STO:PRO) Will Use Its Cash Wisely

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Analysis Article Feb 18

Promimic (STO:PRO) Is In A Good Position To Deliver On Growth Plans

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
Analysis Article Oct 24

We're Not Very Worried About Promimic's (STO:PRO) Cash Burn Rate

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
Analysis Article Oct 31

Here's Why We're Not Too Worried About Promimic's (STO:PRO) Cash Burn Situation

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, Promimic ( STO:PRO...
Analysis Article Apr 27

We're Hopeful That Promimic (STO:PRO) Will Use Its Cash Wisely

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...

Revenue & Expenses Breakdown

How Promimic makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OM:PRO Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2551-9470
30 Sep 2553-12500
30 Jun 2550-13490
31 Mar 2550-14510
31 Dec 2449-13510
30 Sep 2445-11500
30 Jun 2444-10490
31 Mar 2442-9460
31 Dec 2339-9440
30 Sep 2334-9380
30 Jun 2329-11350
31 Mar 2322-14320
31 Dec 2217-16290
30 Sep 2214-17280
30 Jun 2211-17260
31 Mar 229-17230
31 Dec 218-15210
31 Dec 206-13170
31 Dec 196-11150
31 Dec 1812-45510

Quality Earnings: PRO is currently unprofitable.

Growing Profit Margin: PRO is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: PRO is unprofitable, but has reduced losses over the past 5 years at a rate of 9.1% per year.

Accelerating Growth: Unable to compare PRO's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: PRO is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (11.1%).


Return on Equity

High ROE: PRO has a negative Return on Equity (-14.81%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/12 10:33
End of Day Share Price 2026/05/12 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Promimic AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.